| Jul 3 |
Sanofi, Regeneron win EU label expansion for Dupixent in COPD
|
| Jul 3 |
EMA approves Sanofi’s Dupixent for COPD treatment in adults
|
| Jul 3 |
Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
|
| Jul 3 |
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
|
| Jul 2 |
Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
|
| Jul 2 |
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
|
| Jul 1 |
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
|
| Jul 1 |
Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
|
| Jul 1 |
Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
|
| Jul 1 |
Sanofi reports findings from Phase II relapsing MS treatment trial
|
